NEW YORK (GenomeWeb) – NanoString Technologies yesterday reported preliminary fourth quarter and full-year 2015 financial results, with total revenues increasing about 40 percent and 30 percent, respectively.

Seattle-based NanoString projected total Q4 revenue of $21.1 million to $22.1 million, an increase of 35 percent to 42 percent over the prior year period. It also expects full-year revenues of $61.5 million to $62.5 million, an increase of 29 percent to 31 percent over fiscal year 2014, and within the firm's guidance of $60 million to $63 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.